Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States.
Gyre Therapeutics stock last closed at $17.11, up 4.78% from the previous day, and has increased 395.94% in one year. It has overperformed other stocks in the Biotechnology industry by 4.18 percentage points. Gyre Therapeutics stock is currently +470.33% from its 52-week low of $3.00, and -43.72% from its 52-week high of $30.40.
As of Apr 26, 2024, there are 85.42M shares of GYRE outstanding. The market cap of GYRE is $1.46B. In the past 24 hours, 190,123 GYRE shares were traded.
How to Buy Gyre Therapeutics Stock
Not sure how to invest in Gyre Therapeutics stock? Here's how.
Figure out where to buy Gyre Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Gyre Therapeutics stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Choose your payment method and add your info.
Research Gyre Therapeutics stock: The Gyre Therapeutics ticker symbol is GYRE. Is Gyre Therapeutics stock a good investment? Should you buy shares of GYRE? How do GYRE's underlying business fundamentals look? Do top analysts think Gyre Therapeutics is a good buy? Why has GYRE's stock price moved recently? (Hint: Our stock research tools can help you evaluate if GYRE is a good stock to buy).
Place your GYRE trade: Decide if you will purchase GYRE shares at the current market price or use a limit order to purchase GYRE stock at a given price.
Get key alerts regarding your investment in GYRE: Create a watchlist to keep track of your position in Gyre Therapeutics stock.
Step 1: Figure out where to buy Gyre Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy GYRE stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world markets: From Technology to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you are able to invest in GYRE today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Gyre Therapeutics stock
After you have figured out the best place to buy Gyre Therapeutics stock, it's absolutely critical to research their stock prior to buying, so you actually comprehend the risk as well as the upside.
Gyre Therapeutics shares at a glance
GYRE Price
$17.11
1w %
10.32%
1y %
395.94%
5y %
-86.39%
P/E
-12.13x
P/B
-92.34x
P/S
9.93x
PEG
N/A
Revenue
$113.45M
Earnings
-$92.93M
Fore. Rev. Growth
-23.95%
Fore. Earn. Growth
N/A
Market Cap
$1.46B
Next Earnings
May 13, 2024
Next Dividend
N/A
Fundamentals of GYRE
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.
Last year, GYRE revenue was $113.45M. In the past three year, GYRE's revenue has gone up by 164.06% per year. This was faster than the Biotechnology industry average of 28.56%.
No, Gyre Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about GYRE
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your GYRE trade
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally sufficient.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a given price, use a limit order.
Click the Open button and your broker will place your order.
If you require more help with buying stocks on eToro, watch the how to video below:
How much does it cost to buy one Gyre Therapeutics share?
As of Apr 26, 2024, it costs $17.11 to buy one share of Gyre Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $8, you can buy 0.468 shares of GYRE.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.